Edition:
United States

Valeant Pharmaceuticals International Inc (VRX.N)

VRX.N on New York Stock Exchange

13.77USD
4:01pm EDT
Change (% chg)

$-0.02 (-0.15%)
Prev Close
$13.79
Open
$13.86
Day's High
$13.94
Day's Low
$13.64
Volume
921,504
Avg. Vol
3,057,552
52-wk High
$27.84
52-wk Low
$8.32

Chart for

About

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment,... (more)

Overall

Beta: -0.38
Market Cap(Mil.): $4,785.40
Shares Outstanding(Mil.): 347.33
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.87 16.18
EPS (TTM): -- -- --
ROI: -- 15.15 14.60
ROE: -- 16.38 13.87

BRIEF-Ortho Dermatologics submits NDA to U.S. FDA for psoriasis treatment IDP-118

* Ortho dermatologics submits new drug application to the u.s. Food and drug administration for psoriasis treatment idp-118

Sep 05 2017

BRIEF-Valeant director Richard Deschutter reports purchase of 10,000 shares of co's common stock

* Valeant director Richard Deschutter reports purchase of 10,000 shares of co's common stock on Aug. 21 - SEC filing Source text for Eikon: Further company coverage:

Aug 22 2017

BRIEF-Valeant receives FDA confirmation of inspection for Tampa facility

* Valeant receives FDA confirmation of voluntary action indicated (VAI) inspection classification for tampa facility

Aug 16 2017

BRIEF-Paulson & Co dissolves share stake in Pfizer, ups in Valeant ‍​

* Paulson & Co dissolves share stake in Pfizer- SEC filing ‍​

Aug 14 2017

BRIEF-Hedge fund Paulson & Co trims stake in Valeant

Aug 10 Valeant Pharmaceuticals International Inc -

Aug 09 2017

Hedge fund Paulson & Co trims stake in Valeant

Aug 10 Valeant Pharmaceuticals International Inc investor John Paulson trimmed his stake in the Canadian drugmaker but said he remains fully supportive of the company's leadership.

Aug 09 2017

BRIEF-Paulson & Co reports 6 pct stake in Valeant, as of Aug 9

* Paulson & Co Inc reports 6 percent stake in Valeant as of Aug 9 - SEC filing

Aug 09 2017

BRIEF-Valeant says subsidiaries in Australia are under audit by tax office

* Says subsidiaries in australia are under audit by the australian tax office for various years beginning in 2010‍​

Aug 08 2017

Valeant says it will exceed debt repayment target, shares surge

Canada's Valeant Pharmaceuticals International Inc said on Tuesday it expects to repay more than $5 billion in debt earlier than it had targeted, news that pushed its shares up 9 percent.

Aug 08 2017

UPDATE 3-Valeant says it will exceed debt repayment target, shares surge

Aug 8 Canada's Valeant Pharmaceuticals International Inc said on Tuesday it expects to repay more than $5 billion in debt earlier than it had targeted, news that pushed its shares up 9 percent.

Aug 08 2017

Competitors

Earnings vs. Estimates